This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The Asan Foundation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Eun Mi Hong: Innovator in Protein Kinase Inhibition
Introduction
Eun Mi Hong is a prominent inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of protein kinase inhibitors. Her innovative work is aimed at addressing various diseases through targeted therapies.
Latest Patents
Eun Mi Hong holds a patent for a "Protein kinase inhibitor containing pyrrolopyridazine derivative." This invention relates to a pyrrolopyridazine derivative represented by a specific formula, or a pharmaceutically acceptable salt thereof. The compound is designed to inhibit the activity of protein kinase(s), making it useful for preventing or treating diseases associated with these enzymes. She has 1 patent to her name.
Career Highlights
Eun Mi Hong is affiliated with The Asan Foundation, where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative drug development.
Collaborations
Eun Mi Hong collaborates with notable colleagues, including Tae Gon Baik and Won-Hyuk Jung. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Eun Mi Hong is a dedicated inventor whose work in protein kinase inhibition holds promise for future medical advancements. Her contributions to the field exemplify the impact of innovative research on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile